{"id":"https://openalex.org/W2003166500","doi":"https://doi.org/10.1070/mc1996v006n04abeh000629","title":"\u03b2-Mercaptoguanidine derivatives \u2013 new class of potential NO-generating compounds","display_name":"\u03b2-Mercaptoguanidine derivatives \u2013 new class of potential NO-generating compounds","publication_year":1996,"publication_date":"1996-01-01","ids":{"openalex":"https://openalex.org/W2003166500","doi":"https://doi.org/10.1070/mc1996v006n04abeh000629","mag":"2003166500"},"language":"en","primary_location":{"id":"doi:10.1070/mc1996v006n04abeh000629","doi":"https://doi.org/10.1070/mc1996v006n04abeh000629","is_oa":false,"landing_page_url":"https://doi.org/10.1070/mc1996v006n04abeh000629","pdf_url":null,"source":{"id":"https://openalex.org/S19676749","display_name":"Mendeleev Communications","issn_l":"0959-9436","issn":["0959-9436","1364-551X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mendeleev Communications","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004491209","display_name":"Vladimir G. Granik","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Vladimir G. Granik","raw_affiliation_strings":["Centre for Medicinal Chemistry, All-Russian Research Chemical-Pharmaceutical Institute, 119815 Moscow, Russian Federation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Medicinal Chemistry, All-Russian Research Chemical-Pharmaceutical Institute, 119815 Moscow, Russian Federation","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058068932","display_name":"N. B. Grigoriev","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nikita B. Grigoriev","raw_affiliation_strings":["Centre for Medicinal Chemistry, All-Russian Research Chemical-Pharmaceutical Institute, 119815 Moscow, Russian Federation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Medicinal Chemistry, All-Russian Research Chemical-Pharmaceutical Institute, 119815 Moscow, Russian Federation","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009441412","display_name":"Leonid H. Vinograd","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Leonid H. Vinograd","raw_affiliation_strings":["Centre for Medicinal Chemistry, All-Russian Research Chemical-Pharmaceutical Institute, 119815 Moscow, Russian Federation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Medicinal Chemistry, All-Russian Research Chemical-Pharmaceutical Institute, 119815 Moscow, Russian Federation","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110115583","display_name":"Irina S. Severina","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152028","display_name":"Institute of Biomedical Chemistry","ror":"https://ror.org/040wrkp27","country_code":"RU","type":"facility","lineage":["https://openalex.org/I1313323035","https://openalex.org/I4210110862","https://openalex.org/I4210152028"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Irina S. Severina","raw_affiliation_strings":["Research Institute of Biomedical Chemistry, Russian Academy of Medical Sciences, 119832 Moscow, Russian Federation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Institute of Biomedical Chemistry, Russian Academy of Medical Sciences, 119832 Moscow, Russian Federation","institution_ids":["https://openalex.org/I4210152028"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060657993","display_name":"Michael D. Mashkovskyi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael D. Mashkovskyi","raw_affiliation_strings":["Centre for Medicinal Chemistry, All-Russian Research Chemical-Pharmaceutical Institute, 119815 Moscow, Russian Federation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Medicinal Chemistry, All-Russian Research Chemical-Pharmaceutical Institute, 119815 Moscow, Russian Federation","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111624719","display_name":"V. B. Nikitin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Valery B. Nikitin","raw_affiliation_strings":["Centre for Medicinal Chemistry, All-Russian Research Chemical-Pharmaceutical Institute, 119815 Moscow, Russian Federation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Medicinal Chemistry, All-Russian Research Chemical-Pharmaceutical Institute, 119815 Moscow, Russian Federation","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068915467","display_name":"\u0413. \u041d. \u0415\u043d\u0433\u0430\u043b\u044b\u0447\u0435\u0432\u0430","orcid":"https://orcid.org/0000-0001-5121-0858","observed_orcids":["https://orcid.org/0000-0001-5121-0858"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Galina N. Engalycheva","raw_affiliation_strings":["Centre for Medicinal Chemistry, All-Russian Research Chemical-Pharmaceutical Institute, 119815 Moscow, Russian Federation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Medicinal Chemistry, All-Russian Research Chemical-Pharmaceutical Institute, 119815 Moscow, Russian Federation","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077912020","display_name":"\u041c. \u0410. \u041a\u0430\u043b\u0438\u043d\u043a\u0438\u043d\u0430","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marina A. Kalinkina","raw_affiliation_strings":["Centre for Medicinal Chemistry, All-Russian Research Chemical-Pharmaceutical Institute, 119815 Moscow, Russian Federation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Medicinal Chemistry, All-Russian Research Chemical-Pharmaceutical Institute, 119815 Moscow, Russian Federation","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077181124","display_name":"Olga G. Busigina","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152028","display_name":"Institute of Biomedical Chemistry","ror":"https://ror.org/040wrkp27","country_code":"RU","type":"facility","lineage":["https://openalex.org/I1313323035","https://openalex.org/I4210110862","https://openalex.org/I4210152028"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Olga G. Busigina","raw_affiliation_strings":["Research Institute of Biomedical Chemistry, Russian Academy of Medical Sciences, 119832 Moscow, Russian Federation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Institute of Biomedical Chemistry, Russian Academy of Medical Sciences, 119832 Moscow, Russian Federation","institution_ids":["https://openalex.org/I4210152028"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5004491209"],"corresponding_institution_ids":[],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":null,"fwci":0.2232,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.48015403,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"6","issue":"4","first_page":"161","last_page":"163"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10155","display_name":"Nitric Oxide and Endothelin Effects","score":0.9580000042915344,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10155","display_name":"Nitric Oxide and Endothelin Effects","score":0.9580000042915344,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.01600000075995922,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12410","display_name":"Structural and Chemical Analysis of Organic and Inorganic Compounds","score":0.00430000014603138,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nitric-oxide-production","display_name":"nitric oxide production","score":0.8759999871253967},{"id":"https://openalex.org/keywords/soluble-guanylate-cyclase-activation","display_name":"soluble guanylate cyclase activation","score":0.9559999704360962},{"id":"https://openalex.org/keywords/blood-pressure-reduction","display_name":"blood pressure reduction","score":0.7400000095367432},{"id":"https://openalex.org/keywords/guanylate-cyclase-inhibitor","display_name":"guanylate cyclase inhibitor","score":0.5059999823570251}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9708243012428284},{"id":"https://openalex.org/C2777212361","wikidata":"https://www.wikidata.org/wiki/Q5127848","display_name":"Class (philosophy)","level":2,"score":0.5884813070297241},{"id":"https://openalex.org/C147597530","wikidata":"https://www.wikidata.org/wiki/Q369472","display_name":"Computational chemistry","level":1,"score":0.42399898171424866},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.3698756992816925},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.3260272741317749},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1070/mc1996v006n04abeh000629","doi":"https://doi.org/10.1070/mc1996v006n04abeh000629","is_oa":false,"landing_page_url":"https://doi.org/10.1070/mc1996v006n04abeh000629","pdf_url":null,"source":{"id":"https://openalex.org/S19676749","display_name":"Mendeleev Communications","issn_l":"0959-9436","issn":["0959-9436","1364-551X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mendeleev Communications","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8999999761581421,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":9,"referenced_works":["https://openalex.org/W1929009802","https://openalex.org/W1975982125","https://openalex.org/W2007737411","https://openalex.org/W2023516550","https://openalex.org/W2034769077","https://openalex.org/W2051194665","https://openalex.org/W2059737226","https://openalex.org/W2143115897","https://openalex.org/W2326163067"],"related_works":["https://openalex.org/W2411745893","https://openalex.org/W7217713124","https://openalex.org/W1546414073","https://openalex.org/W2073172856","https://openalex.org/W2035505594","https://openalex.org/W2037053134","https://openalex.org/W2623666403","https://openalex.org/W2900288134","https://openalex.org/W1981406314","https://openalex.org/W2045900039"],"abstract_inverted_index":{"\u03b2-Mercaptoguanidine":[0],"derivatives":[1],"generate":[2],"nitric":[3],"oxide":[4],"under":[5],"oxidation":[6],"in":[7,10],"vitro":[8],"and":[9,16],"vivo,":[11],"activate":[12],"soluble":[13],"guanylate":[14],"cyclase":[15],"diminish":[17],"arterial":[18],"blood":[19],"pressure.":[20]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}